奥美医疗 - Financials

奥美医疗 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	3.3B	2.8B	4.2B	2.9B	3.8B
Revenue Growth %	20.6%	-34.5%	43.9%	-23.7%	--
Total Revenue	3.3B	2.8B	4.2B	2.9B	3.8B
Cost Of Revenue	2.4B	2.0B	2.8B	2.0B	2.2B
+Gross Profit	957.0M	769.0M	1.4B	882.0M	1.6B
Gross Margin %	28.8%	27.9%	33.6%	30.1%	41.7%
Total Operating Cost	2.9B	2.6B	3.6B	2.5B	2.6B
Selling Expenses	95.9M	65.7M	83.8M	74.5M	38.2M
Admin Expenses	282.0M	324.0M	366.0M	295.0M	252.0M
Rd Expenses	106.0M	77.4M	108.0M	94.6M	118.0M
Finance Expenses	2.3M	39.9M	179.0M	-14.3M	-10.9M
+Operating Income	458.0M	169.0M	525.0M	506.0M	1.3B
Operating Margin %	13.8%	6.1%	12.5%	17.3%	35.0%
Non Operating Income	2.1M	2.7M	1.5M	882,100	3.0M
Non Operating Expenses	6.1M	2.7M	41.7M	1.3M	6.1M
Investment Income	-1.4M	-59.6M	-103.0M	35.8M	44.1M
Fair Value Change Income	-21.9M	52.7M	-57.6M	6.1M	481,000
Asset Disposal Income	28.8M	-72,900	3.5M	1.9M	26.3M
Asset Impairment Loss	32.8M	108.0M	14.8M	7.0M	-14.8M
Other Income	36.4M	42.6M	44.9M	60.7M	72.6M
Income Before Tax	454.0M	169.0M	485.0M	505.0M	1.3B
Income Tax	85.6M	64.8M	80.3M	73.5M	178.0M
+Net Income	369.0M	104.0M	405.0M	432.0M	1.2B
Net Margin %	11.1%	3.8%	9.6%	14.8%	30.3%
Net Income Attributable	369.0M	110.0M	407.0M	431.0M	1.2B
Minority Interest	117,500	-6.2M	-2.1M	745,600	2.9M
Eps Basic	0.59	0.17	0.64	0.68	1.83
Eps Diluted	0.59	0.17	0.64	0.68	1.83

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	585.0M	397.0M	522.0M	678.0M	1.3B
Trading Financial Assets	83.2M	96.8M	265.0M	8.1M	35.6M
Accounts Receivable	478.0M	376.0M	483.0M	425.0M	239.0M
Notes Receivable	1.7M	11.9M	34.5M	84.1M	--
Notes And Accounts Receivable	480.0M	388.0M	518.0M	509.0M	239.0M
Prepayments	55.9M	78.3M	97.6M	37.6M	191.0M
Inventory	615.0M	707.0M	877.0M	847.0M	707.0M
Total Current Assets	1.9B	1.8B	2.4B	2.2B	2.8B
Long Term Equity Investment	845.0M	845.0M	815.0M	749.0M	394.0M
Fixed Assets	--	2.0B	1.6B	1.6B	1.2B
Fixed Assets Total	1.8B	2.0B	1.6B	1.6B	1.2B
Construction In Progress	--	18.4M	401.0M	38.2M	72.2M
Construction In Progress Total	27.0M	18.4M	401.0M	38.2M	72.2M
Intangible Assets	183.0M	203.0M	214.0M	235.0M	220.0M
Long Term Deferred Expenses	6.8M	7.1M	4.7M	1.1M	1.3M
Total Non Current Assets	3.1B	3.3B	3.3B	2.8B	2.0B
Total Assets	5.1B	5.1B	5.7B	5.0B	4.9B
Short Term Borrowings	494.0M	750.0M	792.0M	1.1B	1.1B
Accounts Payable	334.0M	311.0M	499.0M	254.0M	143.0M
Advance Receipts	--	--	--	400,000	--
Contract Liabilities	13.0M	64.8M	129.0M	7.8M	52.5M
Total Current Liabilities	1.1B	1.3B	2.1B	1.6B	1.5B
Long Term Borrowings	89.2M	146.0M	111.0M	128.0M	100.0M
Total Non Current Liabilities	503.0M	548.0M	550.0M	614.0M	468.0M
Total Liabilities	1.6B	1.9B	2.6B	2.3B	1.9B
Paid In Capital	633.0M	633.0M	633.0M	633.0M	633.0M
Capital Reserve	580.0M	566.0M	566.0M	564.0M	573.0M
Surplus Reserve	264.0M	236.0M	202.0M	164.0M	145.0M
Retained Earnings	2.0B	1.7B	1.7B	1.5B	1.6B
Minority Equity	11.5M	23.7M	29.9M	-907,800	12.4M
Equity Attributable	3.4B	3.2B	3.1B	2.8B	2.9B
Total Equity	3.4B	3.2B	3.1B	2.8B	2.9B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	3.3B	2.8B	4.6B	3.2B	4.3B
Tax Refunds Received	223.0M	137.0M	260.0M	165.0M	207.0M
Total Operating Cash Inflow	3.5B	3.0B	5.0B	3.5B	4.7B
Cash Paid For Goods	2.0B	1.7B	2.8B	2.2B	2.6B
Cash Paid To Employees	582.0M	554.0M	617.0M	506.0M	468.0M
Taxes Paid	89.9M	127.0M	166.0M	160.0M	77.6M
Total Operating Cash Outflow	2.8B	2.5B	3.8B	3.1B	3.2B
Operating Cash Flow	712.0M	424.0M	1.1B	375.0M	1.4B
Total Investing Cash Inflow	304.0M	355.0M	1.5B	2.9B	3.4B
Total Investing Cash Outflow	448.0M	570.0M	2.5B	3.4B	4.1B
Investing Cash Flow	-145.0M	-215.0M	-971.0M	-473.0M	-745.0M
Cash From Borrowings	616.0M	1.3B	2.5B	3.2B	1.5B
Dividends And Interest Paid	44.1M	65.2M	164.0M	577.0M	266.0M
Debt Repayments	869.0M	1.5B	3.0B	3.2B	915.0M
Total Financing Cash Inflow	958.0M	1.6B	2.9B	3.2B	1.6B
Total Financing Cash Outflow	1.3B	1.9B	3.1B	3.8B	1.2B
Financing Cash Flow	-390.0M	-329.0M	-236.0M	-553.0M	359.0M
Net Change In Cash	191.0M	-113.0M	-160.0M	-639.0M	1.1B
Ending Cash Balance	580.0M	390.0M	503.0M	663.0M	1.3B
Capex	157.0M	286.0M	398.0M	291.0M	243.0M